Trends in interventional stroke device utilization during the COVID-19 pandemic,Clinical Neurology and Neurosurgery

当前位置： X-MOL 学术 › Clin. Neurol. Neurosurg. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Trends in interventional stroke device utilization during the COVID-19 pandemic
Clinical Neurology and Neurosurgery ( IF 1.8 ) Pub Date : 2021-09-02 , DOI: 10.1016/j.clineuro.2021.106931
Arjun Rohit Adapa ₁ , Mouhammad A Jumaa ₂ , Fazeel M Siddiqui ₃ , Giana Dawod ₄ , Osama O Zaidat ₅ , Hitinder S Gurm ₆ , Aditya S Pandey ₇

Affiliation

Objectives

The collateral effect of the COVID-19 pandemic on interventional stroke care is not well described. We studied this effect by utilizing stroke device sales data as markers of interventional stroke case volume in the United States.

Methods

Using a real-time healthcare device sales registry, this observational study examined trends in the sales of thrombectomy devices and cerebral aneurysm coiling from the same 945 reporting hospitals in the U.S. between January 22 and June 31, 2020, and for the same months in 2018 and 2019 to allow for comparison. We simultaneously reviewed daily reports of new COVID-19 cases. The strength of association between the cumulative incidence of COVID-19 and procedural device sales was measured using Spearman rank correlation coefficient (CC).

Results

Device sales decreased for thrombectomy (− 3.7%) and cerebral aneurysm coiling (− 8.5%) when comparing 2019–2020. In 2020, thrombectomy device sales were negatively associated with the cumulative incidence of COVID-19 (CC − 0.56, p < 0.0001), with stronger negative correlation during April (CC − 0.97, p < 0.0001). The same negative correlation was observed with aneurysm treatment devices (CC − 0.60, p < 0.001), with stronger correlation in April (CC − 0.97, p < 0.0001).

Conclusions

The decline in sales of stroke interventional equipment underscores a decline in associated case volumes. Future pandemic responses should consider strategies to mitigate such negative collateral effects.

中文翻译：

COVID-19 大流行期间介入性卒中设备的使用趋势

目标

没有很好地描述 COVID-19 大流行对介入性卒中护理的附带影响。我们通过使用卒中设备销售数据作为美国介入性卒中病例数量的标志来研究这种影响。

方法

这项观察性研究使用实时医疗器械销售登记表，检查了 2020 年 1 月 22 日至 6 月 31 日期间以及 2018 年同一月份美国 945 家报告医院的血栓切除术设备和脑动脉瘤线圈的销售趋势和 2019 年以便进行比较。我们同时审查了新的 COVID-19 病例的每日报告。使用 Spearman 等级相关系数 (CC) 衡量 COVID-19 累积发病率与程序设备销售之间的关联强度。

结果

与 2019-2020 年相比，血栓切除术 (− 3.7%) 和脑动脉瘤栓塞术 (− 8.5%) 的设备销售额有所下降。2020 年，取栓器械销量与 COVID-19 累计发病率呈负相关（CC − 0.56，p < 0.0001），4 月份负相关性更强（CC − 0.97，p < 0.0001）。动脉瘤治疗装置也观察到相同的负相关性 (CC − 0.60, p < 0.001)，4 月份相关性更强 (CC − 0.97, p < 0.0001)。